
How to Improve ICSI Success Chances: Key Factors Before, During, and After Treatment

Manar Hegazy

Majd Eddin Khaled
Couples preparing for ICSI often ask what they can do to make the treatment succeed.
There is no single step, supplement, diet, or laboratory technique that can guarantee pregnancy or live birth from one cycle.
ICSI outcomes depend on multiple factors, including female age, ovarian reserve, oocyte maturity, sperm factors, ovarian stimulation, embryo development, uterine conditions, laboratory quality, and embryo transfer.
Some factors can be modified, such as smoking and adherence to medication. Others, particularly the biological age of the oocytes, cannot be reversed.
The realistic goal is therefore to identify the factors that matter in each couple and improve the elements that can actually be changed.
Fertiliv helps patients organize testing, previous treatment records, and medical review before starting an ICSI cycle.
What Does ICSI Success Mean?
Success can refer to very different stages.
An egg retrieval can be completed successfully without every oocyte being mature.
Fertilization can occur without every embryo continuing to develop.
A transferable embryo can be created without implantation occurring.
Important outcomes therefore include:
Mature oocytes
Fertilization
Embryo development
Blastocyst formation
Clinical pregnancy
Ongoing pregnancy
Live birth
For patients, live birth is ultimately more meaningful than fertilization alone.
Female Age Is One of the Strongest Factors
Female age has a major influence on assisted-reproduction outcomes, particularly through age-related changes in oocyte chromosome status.
As age increases, patients may experience fewer available oocytes, a higher proportion of chromosomally abnormal embryos, and a greater miscarriage risk.
ICSI helps a sperm enter an oocyte, but it does not reverse age-related chromosomal changes in the egg.
Read also: IVF After Age 40 in Istanbul
Ovarian Reserve Predicts Response, Not Egg Quality
AMH, antral follicle count, age, and previous stimulation response help predict how the ovaries may respond to medication.
They do not directly measure the quality of an individual oocyte.
A patient with diminished ovarian reserve may still obtain a transferable embryo, while a patient with more oocytes may not have every oocyte develop successfully.
Current European Society of Human Reproduction and Embryology guidance emphasizes AMH and antral follicle count primarily as predictors of ovarian response.
More Eggs Are Not the Only Goal
The purpose of stimulation is not to obtain the highest possible number of eggs at any cost.
Treatment aims for an appropriate and safe response.
Medication strategy is individualized according to ovarian reserve, age, previous response, and ovarian hyperstimulation risk.
Read also: IVF Process Step by Step: From Ovarian Stimulation to Embryo Transfer
Monitoring Matters During Stimulation
Ultrasound monitoring follows follicular growth during treatment.
Medication may be adjusted according to ovarian response.
Monitoring helps determine:
Follicle number and size
Need for dose adjustment
Timing of antagonist medication
Timing of final trigger
Risk management
Attending monitoring appointments and following updated instructions are therefore important parts of the treatment cycle.
Final Trigger Timing Is Important
The final oocyte-maturation trigger is closely linked to egg retrieval.
Patients should have clear written instructions for the medication, dose, date, and exact time.
Trigger timing should not be moved to accommodate travel or accommodation without medical instruction.
Oocyte Quality Cannot Be Measured by One Blood Test
There is no simple blood test that directly determines whether an individual egg is genetically normal or capable of producing a live birth.
Age provides important population-level information, while oocyte maturity, fertilization, and embryo development provide further information after retrieval.
Embryo appearance alone also cannot identify every chromosomal abnormality.
Male-Factor Evaluation Still Matters
ICSI is often used in male-factor infertility because it allows one sperm to be injected into each selected mature oocyte.
However, ICSI does not make every sperm-related problem irrelevant.
Evaluation may include semen analysis, medical history, previous surgery, severe sperm abnormalities, azoospermia, and previous treatment outcomes.
Surgical sperm retrieval may be required in selected severe male-factor cases.
Read also: IVF and Micro-TESE in Istanbul for Azoospermia Treatment
Does Every Additional Sperm Test Improve Success?
No.
Additional testing should answer a specific clinical question.
The useful question is:
What will this test identify, and would the result change treatment?
More testing does not automatically mean better outcomes.
Fertilization Is Only One Stage
The number of eggs and embryos can decrease through the laboratory pathway:
retrieved oocytes → mature oocytes → fertilized oocytes → developing embryos → transferable or freezable embryos
This can happen even when a cycle is managed appropriately.
ICSI success should therefore not be judged only by fertilization percentage.
Laboratory Quality Matters
After retrieval, laboratory procedures become a central part of the treatment.
Updated European Society of Human Reproduction and Embryology laboratory guidance emphasizes patient identification, traceability, laboratory conditions, fertilization procedures, embryo assessment, cryopreservation, warming, transfer, documentation, and quality control.
Patients cannot personally audit every laboratory detail, but they can ask about laboratory systems, experience, and traceability.
Is ICSI Automatically Better Than Conventional IVF?
No.
The American Society for Reproductive Medicine's 2026 committee opinion concludes that routine ICSI in patients without male-factor infertility or previous fertilization failure does not improve live-birth rates compared with conventional IVF.
ICSI is highly valuable when there is a clinical indication, but it should not be treated as a universal method for increasing IVF success.
Read also: IVF vs ICSI: What Is the Difference and When Is Each Treatment Used?
Uterine Factors Matter at the Transfer Stage
A good embryo still needs an appropriate uterine environment for transfer.
Assessment may consider:
Uterine cavity
Polyps
Cavity-distorting fibroids
Adhesions
Hydrosalpinx in relevant cases
Endometrial findings
This does not mean every patient needs hysteroscopy or an extensive implantation panel.
Testing should be based on clinical indications.
Does Endometrial Thickness Alone Predict Success?
No.
Endometrial thickness is one part of transfer assessment, not the only determinant.
The physician also considers the transfer protocol, hormonal timing, uterine findings, embryo stage, embryo characteristics, and treatment history.
More Embryos Transferred Is Not Automatically Better
Transferring multiple embryos can increase the risk of multiple pregnancy and its complications.
The goal is not simply to place more embryos in the uterus, but to balance the probability of pregnancy with maternal and fetal safety.
Does PGT Improve Success for Everyone?
No.
Preimplantation genetic testing may have a role in selected treatment plans, but it does not guarantee pregnancy and should not be presented as universally improving live birth.
Its relevance depends on age, embryo number, pregnancy-loss history, treatment history, and whether a specific inherited condition is being investigated.
Read also: IVF With PGT-A and PGT-M in Istanbul
Smoking Is a Modifiable Risk Factor
Smoking is one factor that patients can change.
American Society for Reproductive Medicine guidance reports adverse associations between tobacco use and reproductive outcomes, including assisted reproduction, and also describes adverse effects on sperm parameters.
Both partners should therefore be encouraged to stop smoking and reduce exposure to secondhand smoke before treatment.
Stopping smoking cannot guarantee success, but it removes an avoidable reproductive risk.
Weight and General Health
Obesity can be associated with ovulatory dysfunction, altered response to stimulation, reduced IVF birth rates, and increased pregnancy complications.
However, this does not mean every patient should delay treatment until reaching an “ideal” weight.
The potential benefit of improving metabolic health must be balanced against age and the consequences of delaying fertility treatment.
Management should be individualized.

Is There a Diet That Improves ICSI Success?
No single diet has been proven to guarantee ICSI success.
A balanced dietary pattern is generally more reasonable than restrictive diets or unproven “fertility” programs.
Patients should also be cautious with supplements marketed as guaranteed ways to improve egg quality.
Documented nutritional deficiencies or medical conditions should be treated appropriately.
Supplements Are Not a Substitute for Medical Planning
Evidence differs substantially among fertility supplements.
Avoid high-dose combinations without medical review and inform the treating team about all supplements and nonprescription products.
Treatment should not be delayed for months solely to use an unproven supplement.
Stress Is Not a Personal Cause of Treatment Failure
ICSI can be emotionally demanding.
Sleep, psychological support, and practical help can improve the patient's experience of treatment.
However, patients should not be told that anxiety or stress itself caused an unsuccessful cycle.
Psychological support is valuable for wellbeing and coping, not because calmness guarantees implantation.
Following Instructions Is Something Patients Can Control
Important practical steps include:
Taking medication correctly
Attending monitoring
Following dose changes
Taking the final trigger at the specified time
Reporting new medication or medical problems
Following retrieval and transfer instructions
These steps do not magically improve egg quality, but they help prevent avoidable errors during treatment.
Is Bed Rest Helpful After Embryo Transfer?
Prolonged bed rest has not been shown to improve routine embryo-transfer outcomes.
Most patients can return to normal light activity according to clinical instructions.
What Can and Cannot Be Modified?
| Factor | Can It Be Modified? |
|---|---|
| Biological age of oocytes | No |
| Ovarian reserve | Cannot reliably be increased |
| Smoking | Yes |
| Medication adherence | Yes |
| Monitoring attendance | Yes |
| Control of some chronic conditions | Often |
| General metabolic health | Often |
| Laboratory quality | Depends on treatment provider |
| Number of embryos produced | Cannot be guaranteed |
| Embryonic chromosomal abnormalities | ICSI itself does not prevent them |
| Stimulation protocol | Can be individualized medically |
After a Failed Cycle, Review Before Adding More Treatments
An unsuccessful ICSI cycle should first be reviewed systematically.
Important information includes:
Follicular response
Oocyte yield
Oocyte maturity
Fertilization
Embryo development
Transfer details
Endometrial findings
Pregnancy result
Sometimes this review identifies something worth changing.
In other cases, no specific correctable reason is found.
Read also: What Should You Do If IVF Fails in Your Home Country and You Want Treatment in Turkey?
Before ICSI: Checklist
Ask:
What is the main infertility diagnosis?
Is ICSI specifically indicated?
What is the ovarian reserve?
Is there a significant male factor?
What ovarian response is expected?
Which tests need updating?
Does the uterine cavity need further assessment?
Is fresh transfer or freeze-all more likely?
Is there a clear reason for genetic testing?
Which health factors can we improve?
What happened in previous cycles?
Which outcome is being used when discussing success rates?
Conclusion
Improving ICSI success is not about one secret technique.
Outcomes reflect a combination of:
female age + oocyte number and maturity + male factors + ovarian response + laboratory quality + embryo development + uterine conditions + embryo transfer
Patients can improve some elements by stopping smoking, managing health conditions, following treatment instructions, and providing complete previous records.
Other factors, particularly oocyte age and embryo chromosome status, cannot be reversed by using ICSI.
ICSI itself also does not automatically improve live-birth rates when there is no appropriate indication for using it.
Fertiliv helps couples organize testing and previous treatment information and coordinate medical review before starting an ICSI treatment plan.
Frequently Asked Questions: How to Improve ICSI Success Chances: Key Factors Before, During, and After Treatment
What Is the Most Important Factor Affecting ICSI Success?
There is no single factor, but female age and oocyte and embryo biology are among the strongest predictors.
Can Ovarian Reserve Be Increased Before ICSI?
There is no proven treatment that reliably restores the number of remaining oocytes, although ovarian reserve testing helps plan stimulation.
Do More Eggs Always Mean Better Success?
No. The goal is an appropriate response with mature oocytes while maintaining patient safety.
Is ICSI Better Than Conventional IVF for Everyone?
No. It is especially useful for male-factor infertility and selected fertilization problems.
Does Smoking Affect ICSI Outcomes?
Smoking is associated with adverse reproductive outcomes and should be stopped before fertility treatment when possible.
Can Diet or Supplements Guarantee Better Egg Quality?
No diet or supplement has been shown to guarantee improved egg quality or ICSI success.
Does Bed Rest After Transfer Improve Success?
Prolonged bed rest has not been shown to improve routine embryo-transfer outcomes.
What Should Be Done After a Failed ICSI Cycle?
Review stimulation, oocyte maturity, fertilization, embryo development, uterine findings, and transfer before adding new tests or treatments.
